ARCHIVES

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

This article is from The Cancer Letter archive.

Vol. 24 No. 33 | September 4, 1998

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

Antman, Clanton begin work at NCI.

December 5, 2003

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

June 2, 1995

DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies

May 19, 1989

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001